
Synexa Life Sciences expands operations in North America with new Rockville laboratory site
World Leaders in Biomarker and Bioanalysis Research Services
Biomarker & Bioanalytical expertise
Synexa Life Sciences has been providing expert insights for the clinical development of therapeutics for almost 20 years.
Insights that will improve the quality of decision-making through each stage of a therapeutic’s development.
Invaluable insight into the bioanalytical profile of large molecule therapeutics.
Our human in vitro translational ProtoTrials® platform provides unique and translatable insights into a therapeutic’s potential, safety and efficacy.
Services &
Capabilities
Synexa Life Sciences has been providing expert insights for the clinical development of therapeutics for almost 20 years.
services
capabilities
- Cell and gene therapy bioanalysis
- Large and novel molecule bioanalysis
- Vaccines
- Biosimilars
- Functional and translational assays
- Biomarker discovery, detection and interpretation
Synexa specializes across a wide range of therapeutic areas with special focus in immunology, immuno-oncology, autoimmunity among other areas.
Bridging the gap between science and life.
Discuss real solutions to develop your therapeutic pipeline.
Join our next live webinar
Join us as we discuss overcoming challenges to COVID-19 clinical trials, on Tues 27 Jul 2021.
News and
articles
- April 22, 2022
Fibrosis and SMAD signalling
- March 24, 2022
Lipids as Biomarkers of Brain Disorders
- February 28, 2022
Synexa raises awareness for Rare Diseases Day
- May 20, 2021
Behind the wave
- January 20, 2021
Immunogenicity 101: Antidrug Antibodies, Neutralizing Antibodies, and everything in between
- October 2, 2020